5. Liu Jieying, Chen Siyuan, Lv Li, et al. Recent progress in studying curcumin and its nano-preparations for cancer therapy. Curr Pharm Des, 2013, 19(11): 1974-1993.
[6]
6. Duan Jinghua, Zhang Yangde, Han Shiwei, et al. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm, 2010, 400(1/2): 211-220.
[7]
7. Mulik R, Mahadik K, Paradkar A. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study. Eur J Pharm Sci, 2009, 37(3/4): 395-404.
[8]
8. Hani U, Shivakumar H G, Srivastava A, et al. Design and optimization of curcumin-HPβCD bioadhesive vaginal tablets by 23 factorial design: in vitro and in vivo evaluation. J Pharm Innov, 2015, 10(1): 21-35.
[9]
9. Doppalapudi S, Jain A, Khan W, et al. Biodegradable polymers—an overview. Polym Adv Technol, 2014, 25(5, SI): 427-435.
[10]
10. ？uri？ A, Keller B L, Reul R A, et al. Development and lyophilization of itraconazole loaded poly(butyl cyanoacrylate) nanospheres as a drug delivery system. Eur J Pharm Sci, 2015, 78(14): 121-131.
[11]
11. Tian Xinhua, Lin Xiaoning, Wei Feng, et al. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomedicine, 2011, 6(6): 445-452.
13. Maskarinec S A, Hannig J, Lee R C, et al. Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys J, 2002, 82(3): 1453-1459.
[14]
14. Mitra A, Lin Senshang. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. J Pharm Pharmacol, 2003, 55(7): 895-902.
[15]
15. Illum L, Khan M, Mak E. Evaluation of carrier capacity and release characteristics for poly(butyl 2-cyanoacrylate) nanoparticles. Int J Pharm, 1986, 30(1): 17-28.
